| Santhi Nimmagadda, MD | |
|
19001 Hubbard Dr, Dearborn, MI 48126-2637 | |
| (313) 441-1160 | |
| (313) 441-1870 |
| Full Name | Santhi Nimmagadda |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 26 Years |
| Location | 19001 Hubbard Dr, Dearborn, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922029958 | NPI | - | NPPES |
| 04783 | Other | PARAMOUNT | |
| 000000390002 | Other | ANTHEM BCBS | |
| 2621176 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 4301076231 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greenfield Hs - Dearborn | Dearborn, MI | Dialysis facility |
| Henry Ford Hospital | Detroit, MI | Hospital |
| Henry Ford Wyandotte Hospital | Wyandotte, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
News Archive
A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.
According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.
Gov. Rick Perry was expected to begin weighing a Republican presidential bid this week but instead found himself enmeshed again in the battle over the state budget. Political watchers here will scrutinize the governor's special-session agenda for clues to his national intentions. So far, besides the budget, it includes a long-term overhaul of Medicaid and redrawing congressional districts.
To decide whether a new medical technology is cost effective, researchers often "compare a new technology's incremental cost-effectiveness ratio or ICER to a threshold that is some multiple of a country or income group's GDP per capita, per WHO convention," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the CGD's "Global Health Policy" blog
Rebound hyperthermia, or fever, is common after controlled body cooling to treat comatose survivors of cardiac arrest, but a new study presents evidence of significantly worse neurologic outcomes.
› Verified 3 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.
According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.
Gov. Rick Perry was expected to begin weighing a Republican presidential bid this week but instead found himself enmeshed again in the battle over the state budget. Political watchers here will scrutinize the governor's special-session agenda for clues to his national intentions. So far, besides the budget, it includes a long-term overhaul of Medicaid and redrawing congressional districts.
To decide whether a new medical technology is cost effective, researchers often "compare a new technology's incremental cost-effectiveness ratio or ICER to a threshold that is some multiple of a country or income group's GDP per capita, per WHO convention," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the CGD's "Global Health Policy" blog
Rebound hyperthermia, or fever, is common after controlled body cooling to treat comatose survivors of cardiac arrest, but a new study presents evidence of significantly worse neurologic outcomes.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Santhi Nimmagadda, MD 19001 Hubbard Dr, Dearborn, MI 48126-2637 Ph: (313) 441-1160 | Santhi Nimmagadda, MD 19001 Hubbard Dr, Dearborn, MI 48126-2637 Ph: (313) 441-1160 |
News Archive
A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.
According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime.
Gov. Rick Perry was expected to begin weighing a Republican presidential bid this week but instead found himself enmeshed again in the battle over the state budget. Political watchers here will scrutinize the governor's special-session agenda for clues to his national intentions. So far, besides the budget, it includes a long-term overhaul of Medicaid and redrawing congressional districts.
To decide whether a new medical technology is cost effective, researchers often "compare a new technology's incremental cost-effectiveness ratio or ICER to a threshold that is some multiple of a country or income group's GDP per capita, per WHO convention," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the CGD's "Global Health Policy" blog
Rebound hyperthermia, or fever, is common after controlled body cooling to treat comatose survivors of cardiac arrest, but a new study presents evidence of significantly worse neurologic outcomes.
› Verified 3 days ago
Albagir Mohamed Alarabi, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Rama V Thyagarajan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd Ste 101, Medical Office Building, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 | |
Adeeb M Atassi, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 18181 Oakwood Blvd, Suite Number 208, Dearborn, MI 48124 Phone: 313-563-3332 | |
Mihaela A. Lupu, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Ste 208, Dearborn, MI 48124 Phone: 313-271-5670 Fax: 313-271-1053 | |
Violet Asfour, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 18100 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-436-2578 | |
Raed Haddad, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9720 Dix, Ste B, Dearborn, MI 48120 Phone: 313-843-1973 Fax: 313-843-1961 | |
Dr. Denise Kirsch, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd Ste 101, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 |